Search research articles
Contact Us
Filters
Showing results (1-10 of 13) with videos related to
Page
of 2
Sort By:
British Medical Journal (Clinical Research Ed.)
|
May 28, 1983
Alpha blockers and converting enzyme inhibitors
P K Marrott, M Cohen
British Medical Journal (Clinical Research Ed.)
|
December 4, 1982
Death due to overdose of indoramin
P K Marrott, J F Waterfall
British Journal of Clinical Pharmacology
|
February 1, 1979
Haemodynamic and electrocardiographic effects of intravenous disopyramide (rythmodan) following acute myocardial infarction
G J Davies, P K Marrott, J R Muir
Postgraduate Medical Journal
|
October 1, 1970
Pseudohyperaldosteronism induced by habitual ingestion of liquorice
A M Holmes, J Young, P K Marrott, et al.
Journal of Cardiovascular Pharmacology
|
January 1, 1986
Antihypertensive therapy with indoramin: risk-benefit profile in clinical practice
M Stannard, M Cohen, P K Marrott, et al.
European Journal of Clinical Pharmacology
|
January 1, 1984
Pharmacokinetics of oral indoramin in elderly and middle-aged female volunteers
H M Norbury, R A Franklin, P K Marrott, et al.
European Journal of Clinical Pharmacology
|
January 1, 1983
Pharmacokinetics of intravenous indoramin in middle-aged male and female volunteers
H M Norbury, R A Franklin, P K Marrott, et al.
Pediatric Cardiology
|
April 1, 1984
Idiopathic infantile arterial calcification with survival to adult life
P K Marrott, K D Newcombe, D M Becroft, et al.
British Journal of Clinical Pharmacology
|
August 1, 1975
Disopyramide: a study of its acute electrophysiological and haemodynamic effects [proceedings]
P K Marrott, M S Ruttley, J T Winterbott, et al.
The New Zealand Medical Journal
|
September 22, 1982
Intravenous nitroglycerin in acute coronary artery disease
P K Marrott, P L Nairn, C J Dawson, et al.
Page
of 2
Search research articles
Search
Showing results (1-10 of 13) with videos related to
Sort By:
Page
of 2
British Medical Journal (Clinical Research Ed.)
|
May 28, 1983
Alpha blockers and converting enzyme inhibitors
P K Marrott, M Cohen
British Medical Journal (Clinical Research Ed.)
|
December 4, 1982
Death due to overdose of indoramin
P K Marrott, J F Waterfall
British Journal of Clinical Pharmacology
|
February 1, 1979
Haemodynamic and electrocardiographic effects of intravenous disopyramide (rythmodan) following acute myocardial infarction
G J Davies, P K Marrott, J R Muir
Postgraduate Medical Journal
|
October 1, 1970
Pseudohyperaldosteronism induced by habitual ingestion of liquorice
A M Holmes, J Young, P K Marrott, et al.
Journal of Cardiovascular Pharmacology
|
January 1, 1986
Antihypertensive therapy with indoramin: risk-benefit profile in clinical practice
M Stannard, M Cohen, P K Marrott, et al.
European Journal of Clinical Pharmacology
|
January 1, 1984
Pharmacokinetics of oral indoramin in elderly and middle-aged female volunteers
H M Norbury, R A Franklin, P K Marrott, et al.
European Journal of Clinical Pharmacology
|
January 1, 1983
Pharmacokinetics of intravenous indoramin in middle-aged male and female volunteers
H M Norbury, R A Franklin, P K Marrott, et al.
Pediatric Cardiology
|
April 1, 1984
Idiopathic infantile arterial calcification with survival to adult life
P K Marrott, K D Newcombe, D M Becroft, et al.
British Journal of Clinical Pharmacology
|
August 1, 1975
Disopyramide: a study of its acute electrophysiological and haemodynamic effects [proceedings]
P K Marrott, M S Ruttley, J T Winterbott, et al.
The New Zealand Medical Journal
|
September 22, 1982
Intravenous nitroglycerin in acute coronary artery disease
P K Marrott, P L Nairn, C J Dawson, et al.
Page
of 2